Oribel Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Oribel Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.93M	Buy	+19,800	New	+$9.51M	0.3%	104
2025 Q4	–	Sell	-40,400	Closed	-$19.6M	–	145
2025 Q3	$19.6M	Buy	+40,400	New	+$18.8M	0.62%	49
2025 Q1	–	Sell	-47,400	Closed	-$25.7M	–	140
2024 Q4	$24.7M	Buy	+47,400	New	+$26.1M	0.84%	45
2024 Q2	–	Sell	-20,500	Closed	-$11.7M	–	91
2024 Q1	$11.9M	Sell	20,500 -91,700	-82%	-$51.5M	0.7%	46
2023 Q4	$59.6M	Buy	+112,200	New	+$54.3M	3.94%	5
2023 Q1	–	Sell	-25,200	Closed	-$13.9M	–	113
2022 Q4	$13.9M	Buy	25,200 +11,500	+84%	+$6.09M	1.42%	28
2022 Q3	$6.95M	Buy	13,700 +800	+6%	+$448K	0.94%	39
2022 Q2	$3.59M	Buy	+12,900	New	+$7.1M	0.39%	63
2022 Q1	–	Sell	-47,700	Closed	-$31.8M	–	190
2021 Q4	$31.8M	Buy	+47,700	New	+$29.8M	1.19%	26

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Oribel Capital Management's TMO Position: Q2 2026 in Review

Oribel Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 19,800 shares worth $9.93M. The stake represents 0.3% of the portfolio and ranks #104 among its holdings. This is a return to the name: Oribel Capital Management previously reported a position in TMO as recently as Q3 2025.

Oribel Capital Management first reported a position in TMO in Q4 2021 and has held it in 9 quarters since. The position peaked at $59.6M in Q4 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Oribel Capital Management held 19,800 shares of Thermo Fisher Scientific worth $9.93M as of Q2 2026.
Thermo Fisher Scientific was a new Oribel Capital Management position in Q2 2026.
Thermo Fisher Scientific made up 0.3% of Oribel Capital Management's portfolio in Q2 2026, its #104 holding.
Oribel Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 9 quarters since.
Oribel Capital Management's Thermo Fisher Scientific position peaked at $59.6M in Q4 2023.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Oribel Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.